Founder & Chairman
Dr. Syngbum (Ben) Kim, DDS, MS
Dr. Kim is a Yale Fellow and Seoul National University-trained physicist whose early research contributed to the active ingredients now found in Sensodyne. He has served as President of the Yale Alumni Association in New York City and holds a Master of Science in Engineering and Applied Physics.
Over a career spanning four decades, he has built and led ventures across investing, real estate, and hedge funds in both New York and South Korea. As Founder and Chairman, he sets the fund's scientific and financial direction — uniting deep capital-markets experience with a lifelong conviction that breakthrough science deserves patient, strategic backing.
His unique position at the intersection of US and Korean life-science ecosystems gives the Fund an unparalleled advantage in sourcing cross-border investment opportunities and building strategic alliances.
